HHS enumerates qui tam fraud cases

U.S. officials are tracking 180 whistleblower cases that accuse drugmakers of defrauding the government via pricing or marketing of prescription meds, the Department of Health and Human Services said. Report 

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.